These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6547050)

  • 21. Suxamethonium is safe in safe hands; mivacurium should also be considered.
    Rashid A; Watkinson M
    Arch Dis Child Fetal Neonatal Ed; 2000 Sep; 83(2):F160-1. PubMed ID: 11012272
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of atracurium in a patient susceptible to malignant hyperthermia.
    Michel PA; Fronefield HP
    Anesthesiology; 1985 Feb; 62(2):213. PubMed ID: 3838224
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction between atracurium and drugs used in anaesthesia.
    Chapple DJ; Clark JS; Hughes R
    Br J Anaesth; 1983; 55 Suppl 1():17S-22S. PubMed ID: 6688011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morbidity after day case laparoscopy. A comparison of two techniques of tracheal anaesthesia.
    Skacel M; Sengupta P; Plantevin OM
    Anaesthesia; 1986 May; 41(5):537-41. PubMed ID: 2942051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atracurium infusion in liver transplantation.
    Farman JV; Turner JM; Blanloeil Y
    Br J Anaesth; 1986; 58 Suppl 1():96S-102S. PubMed ID: 3011045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro degradation of atracurium in human plasma.
    Merrett RA; Thompson CW; Webb FW
    Br J Anaesth; 1983 Jan; 55(1):61-6. PubMed ID: 6687375
    [No Abstract]   [Full Text] [Related]  

  • 27. Rocuronium vs. succinylcholine revisited.
    Strayer RJ
    J Emerg Med; 2010 Sep; 39(3):345-6; author reply 346-7. PubMed ID: 20456897
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of atracurium in anaesthetized man.
    Payne JP; Hughes R
    Br J Anaesth; 1981 Jan; 53(1):45-54. PubMed ID: 7459185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromuscular blocking and autonomic effects of vecuronium and atracurium in the anaesthetized cat.
    Sutherland GA; Squire IB; Gibb AJ; Marshall IG
    Br J Anaesth; 1983 Nov; 55(11):1119-26. PubMed ID: 6139121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Previous safe administrations of neuromuscular blocking agents do not exonerate from the risk of anaphylactic shock.
    Cottenceau V; Dewachter P; Nouette-Gaulain K; Sztark F
    Ann Fr Anesth Reanim; 2008 Jun; 27(6):509.e1-3. PubMed ID: 18572375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dystrophia myotonica and atracurium. A case report.
    Nightingale P; Healy TE; McGuinness K
    Br J Anaesth; 1985 Nov; 57(11):1131-5. PubMed ID: 3840383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment with non-depolarizing neuromuscular blocking agents and suxamethonium-induced increases in resting jaw tension in children.
    Smith CE; Saddler JM; Bevan JC; Donati F; Bevan DR
    Br J Anaesth; 1990 May; 64(5):577-81. PubMed ID: 2354096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The decision to use succinylcholine for critically ill patients should not be based on duration of time in the intensive care unit alone.
    Bittner EA; Martyn JAJ; Gronert GA
    Anesth Analg; 2013 May; 116(5):1182. PubMed ID: 23606469
    [No Abstract]   [Full Text] [Related]  

  • 34. Prolonged suxamethonium-induced apnoea as a sign of organophosphate poisoning.
    Seybold R; Bräutigam KH
    Ger Med Mon; 1969 Jan; 14(1):12-3. PubMed ID: 5352736
    [No Abstract]   [Full Text] [Related]  

  • 35. In response.
    Blanié A; Ract C; Mazoit JX; Vigué B
    Anesth Analg; 2013 May; 116(5):1182-1183. PubMed ID: 23738350
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review.
    Mirzakhani H; Welch CA; Eikermann M; Nozari A
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):3-16. PubMed ID: 22092267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and pharmacodynamics of atracurium with and without previous suxamethonium administration.
    Donati F; Gill SS; Bevan DR; Ducharme J; Theoret Y; Varin F
    Br J Anaesth; 1991 May; 66(5):557-61. PubMed ID: 2031815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of neuromuscular blocking agents.
    Fisher DM
    Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S4-9. PubMed ID: 10437710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atracurium: neuromuscular blockade in repeated administration].
    Kube D; Schuh FT
    Anaesthesist; 1985 Dec; 34(12):639-44. PubMed ID: 2869712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myoneural blockers and suxamethonium.
    Eisenkraft JB; Herlich A
    Br J Anaesth; 1988 Nov; 61(5):642. PubMed ID: 3207536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.